MSD
About MSD
Merck is a global biopharmaceutical company focused on discovering and delivering medicines and vaccines to address major health threats. The company operates worldwide, advancing research and development across areas such as oncology, infectious diseases, vaccines, cardiovascular disease, immunology, neuroscience, and ophthalmology. It emphasizes following the science to improve lives, conduct clinical trials, and invest in sustainable initiatives and patient-centric programs. Merck traces its heritage to Merck & Co. in the United States and operates under the MSD brand internationally to advance medical science and public health.
Recent News
NHS to Roll Out ‘1-Minute’ Immunotherapy Jab to Tens of Thousands with Cancer
Macrocycles: Big Is the New Beautiful
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
Late-Breakers to Look Out for at ASCO 2026
15 Companies You’ll See at NIBRT Careers in Biopharma 2026
Clinical Trials Day 2026: ‘Research Rising’ Theme Reflected in Q1 Study Growth
GSK/Tesaro Claim Denied in Jemperli Lawsuit with AnaptysBio
Pushy NHS Chatbots 'Can Put Patients Off Screening'
What Are some of the Top Biopharmas Looking for in a Job Applicant?
NICE Backs Stomach Cancer, PAH Drugs for NHS Use
22 Emerging Leaders Selected for Advancing Beef Leaders Program
Moderna Jab on Trial for Cancer-Causing Syndrome
Moderna's Q1 Revenues Rocket, Thanks to Ex-US Sales
ASCO26: Cancer Vaccines and At-Home Injectable Drugs Continue to Show Promise
Magna Mining Site Visit Debrief with CEO Jason Jessup
ASCO26: Verzenio Gives Hope of Liposarcoma Treatment Advance
Manufacturing Hangover Drives Daiichi Sankyo Into the Red